SenesTech (NASDAQ:SNES) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES) in a research note released on Monday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright increased their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.

SenesTech Price Performance

NASDAQ:SNES opened at $2.24 on Monday. SenesTech has a one year low of $1.90 and a one year high of $9.80. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32. The firm has a market cap of $2.32 million, a price-to-earnings ratio of -0.22 and a beta of 0.09. The firm’s fifty day moving average is $2.99 and its two-hundred day moving average is $2.84.

SenesTech (NASDAQ:SNES) last posted its quarterly earnings results on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, beating the consensus estimate of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The company had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.71 million. Research analysts expect that SenesTech will post -10.22 EPS for the current year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.